Table. 2.

Table. 2.

Postoperative complications

Outcome of interest LC + LBDE (n = 256) All LCs (n = 8,489) (includes patients without BDS) p-valuea)
Length of hospital stay in days
Acute 6 (4–11) 5 (3–8) < 0.01*b)
Elective 1 (1–4) 0 (0–1) < 0.01*b)
Postoperative hospital stay in days
Acute 2 (1–5) 2 (1–3) < 0.01*b)
Elective 1 (1–4) 0 (0–1) < 0.01*b)
Bile leak 12 (4.7) 105 (1.2) < 0.01*
Retained stone 8 (3.1) 73 (0.9) < 0.01*
Pancreatitis 4 (1.6) 31 (0.4) 0.02*
Intra-abdominal collection 9 (3.5) 175 (2.1) 0.12
Wound infection 8 (3.1) 172 (2.0) 0.26
Delayed bile duct Injury 2 (0.8) 5 (0.1) 0.02*
Re-imaging 46 (18.0) 607 (7.2) < 0.01*
Postoperative ERCP 18 (7.0) 156 (1.8) < 0.01*
Re-laparoscopy 2 (0.8) 59 (0.7) 0.70
Re-laparotomy 1 (0.4) 32 (0.4) 0.63
30-day complications
ED presentations 31 (12.1) 661 (7.8) 0.02*
Readmissions 31 (12.1) 582 (6.9) < 0.01*
Complications 55 (21.5) 876 (10.3) < 0.01*
Mortality 1 (0.4) 9 (0.1) 0.26

Values are presented as median (interquartile range) or number (%).

The “LC” column includes all LCs (including those performed in patients without BDS, which make up the majority).

This table does not include complications of ERCP (data not available).

LC, laparoscopic cholecystectomy; LBDE, laparoscopic bile duct exploration; BDS, bile duct stones; ERCP, endoscopic retrograde cholangiopancreatography; ED, Emergency Department.

a)Fisher’s exact test was used for all statistical tests except b)where the Mann–Whitney U-test was used. Statistically significant (*p < 0.05).

Ann Hepatobiliary Pancreat Surg 2022;26:333-8 https://doi.org/10.14701/ahbps.22-001
© 2022 Ann Hepatobiliary Pancreat Surg